Warfarin Genetic Test Not Cost Effective for Initial Dosing | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic testing for initial warfarin dosing is not cost effective for most patients, according to research appearing online today in the Annals of Internal Medicine. Instead, the study suggested, such tests may be more suitable for those at high risk of hemorrhaging.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.